Genetic Factors Can Predict the Progression of Parkinson’s Disease

New Report Published in the Journal of Parkinson's Disease

December 16, 2011 - Parkinson’s disease is marked by the abnormal accumulation of α-synuclein and the early loss of dopamine neurons in the substantia nigra region of the brain. A polymorphism in the promotor of α-synuclein gene known as NACP-Rep1 has been implicated as a risk factor for the disease. Now, researchers have found that different variants of NACP-Rep1 and its interaction with the microtubule-associated protein tau (MAPT) H1 haplotype can influence the speed of clinical deterioration in patients with Parkinson’s disease. More...

December 16, 2011

Bulletin 2011/4

December 1, 2011 - Download Bulletin 2011/4 here. More...

December 1, 2011

Patients with Balance Disorders Benefit from Integrative Therapy

State-of-the-Art in Vestibular Rehabilitation Presented in a Special issue of NeuroRehabilitation

November 28, 2011 - Over the last 25 years, intensive efforts by physicians, physical therapists, and occupational therapists have developed integrative rehabilitation regimens that can alleviate balance disorders associated with neurological disease, trauma or weightlessness. A special issue of NeuroRehabilitation: An Interdisciplinary Journal provides an up-to-date review of the underlying scientific principles and latest clinical advances in the treatment of vestibular problems commonly encountered in neurorehabilitation. The journal is celebrating its 20th anniversary of publication this year. More...

November 28, 2011

New Study Challenges Accepted Approaches to Research in Senile Dementia (Alzheimer’s Disease)

November 7, 2011 - Amsterdam, NL, 7 November 2011 – Impacting millions of families and devouring billions of dollars globally, Alzheimer’s disease is the focus of exhaustive research to find a cure. Although intensely investigated over the last three decades using cutting-edge technologies, the “pathogenic cause” of Alzheimer’s disease has not been found. While many research “breakthroughs” have been claimed and high-profile drugs trials carried out, why does the promised “cure” still seem to elude scientists? More...

November 7, 2011